GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Procyon PCYN · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.18

—

Close of 27 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$6.7m

FY2016FY2025

Net income

$33,890

FY2016FY2025

Free cash flow

−$495,350

FY2016FY2025

Shareholders' equity

$2.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$6.7m$5.0m$4.7m$4.8m$4.7m$4.3m$4.2m$4.0m$4.0m$3.4m
Research and development$30,260$30,100$30,600$30,000$30,900$23,093$33,140$41,747$31,298$20,040
Operating income−$446,533−$231,705−$97,381−$237,215$226,674$153,016$97,073$127,085$29,964−$103,572
Net income$33,890−$341,140−$50,245−$209,790$694,349$111,658$27,224−$255,727$12,378$109,569
Diluted earnings per share0.00-0.04-0.01-0.030.090.010.00-0.030.000.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$3.4m$3.2m$3.6m$3.8m$4.2m$2.8m$2.4m$2.4m$2.7m$3.1m
Cash and short-term investments$413,474$908,820$1.0m$1.0m$1.5m$820,966$444,238$423,770$275,314$211,168
Total liabilities$1.1m$917,122$946,000$1.1m$1.3m$657,925$375,935$326,476$442,311$848,595
Debt$139,206$319,876$493,447$856,845$807,882$201,000—$2,110$5,898$134,686
Shareholders' equity$2.3m$2.3m$2.6m$2.7m$3.0m$2.2m$2.1m$2.0m$2.3m$2.3m
Shares outstanding8m8m8m8m8m8m8m8m8m8m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$440,849−$61,251$145,466−$229,459$279,500$198,772$50,837$86,499$199,560$18,682
Capital spending−$54,501−$63,912−$180,138−$82,644−$65,166−$23,044−$28,753−$46,727−$35,856−$73,271
Free cash flow−$495,350−$125,163−$34,672−$312,103$214,334$175,728$22,084$39,772$163,704−$54,589
Dividends paid——————−$17,710———

Latest quarters

By quarter end

Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022
Revenue$1.4m$1.4m$1.2m$1.2m$1.2m$1.2m$1.1m$1.2m
Operating income$8,893$8,893−$81,790−$101,410−$57,391−$3,153−$51,230−$31,545
Net income$37,976$37,976−$102,788−$242,473−$33,855$7,491−$29,471−$20,078
Diluted earnings per share0.000.00-0.01-0.03-0.000.00-0.00-0.00
Total assets$3.2m$3.2m$3.5m$3.2m$3.4m$3.6m$3.6m$3.5m
Cash and short-term investments$908,820—$901,652$838,748$969,088$1.0m$882,172$886,171
Debt$180,665—$178,861$177,083$175,317$173,565$169,169$166,944
Shareholders' equity$2.3m$2.3m$2.2m$2.4m$2.6m$2.6m$2.6m$2.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.3%9.0%9.2%
Operating income23.5%—2.7%
Net income—-21.2%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-5.8%-4.8%-2.1%-1.7%
Net margin-2.6%-2.7%0.8%-0.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings18.3-2.0-9.8-3.91.511.78.3-0.911.80.6
Price to sales0.10.10.10.20.20.30.10.10.00.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-8%30%-37%-20%-25%566%14%46%85%134%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.